Chief Data Officer
Iain McFadyen is a computational scientist who combines demonstrated leadership and strategic vision with an exceptionally broad technical wingspan ranging from genomics, transcriptomics, and protein structure analysis to structure-based drug design, chemoinformatics, deep learning, and translational bioinformatics.
Prior to LifeMine, Iain held positions of increasing responsibility at Moderna, Inc., where he headed up Computational Sciences and Next Generation Analytics. He built a department applying bioinformatics, computational biology, computational chemistry, non-clinical statistics, data science, and NGS to meet the needs of groups and programs across the company. Prior to Moderna, Iain led the development of a big data analytics framework to extract commodity futures trading signals from real-time global geospatial data on maritime cargo movements as an Associate Director at CargoMetrics Technologies, LLC. Before that, Iain was a Principal Research Scientist and Group Leader at TransForm Pharmaceuticals where he led a $10M Grand Challenges in Global Health grant from the Bill & Melinda Gates Foundation. Iain started his career in increasing roles of responsibility at Genetics Institute/Wyeth Research where he ultimately served as a Senior Scientist focused on rational, structure-based drug design and chemoinformatics applied to a variety of protein targets.
Iain earned a Ph.D. in pharmacology from Loughborough University (UK) and the University of Michigan in the Traynor Lab and a B.S. in medicinal and pharmaceutical chemistry from Loughborough University (UK). He was a Postdoctoral Research Associate at the University of Minnesota where he focused on the structural basis of opioid receptor ligand selectivity in the Ferguson Lab.